Plasma neurofilament light chain levels and cognitive testing as predictors of fast progression in Alzheimer’s disease — Roberto Santangelo (2021) | RDL Network
Plasma neurofilament light chain levels and cognitive testing as predictors of fast progression in Alzheimer’s disease
Article 2021 en
Authors
RS
Roberto Santangelo
FA
Federica Agosta
FM
Francesco Di Masi
Abstract
1 min read
An easily applicable algorithm, including plasma NfL measurement and two neuropsychological tests worldwide adopted in clinical practice (SVF and CDT), may allow clinicians to reliably stratify AD patients in relation to the risk of fast cognitive decline.
Liu‐Yun Wu, Cheuk Ni Kan, Irwin K. Cheah, Joyce R. Chong, Xin Xu, Henri A. Vrooman, Saima Hilal, Narayanaswamy Venketasubramanian, Christopher Chen, Barry Halliwell, Mitchell K.P. Lai
Discussion(0)
No comments yet. Be the first to comment.